Vital Therapies Lands $54,000,000 New Funding Round

  • Feed Type
  • Date
    4/16/2014
  • Company Name
    Vital Therapies
  • Mailing Address
    15010 Avenue of Science San Diego, CA 92128 USA
  • Company Description
    Vital Therapies, Inc. (NASDAQ: VTL) is a new company formed in 2003 to continue the development of the ELAD (Extracorporeal Liver Assist Device) System, which augments the metabolic functions of a patient’s liver, thereby enabling a bridge to transplant or liver recovery. VTI acquired the assets and business of VitaGen/Hepatix.
  • Website
    http://www.vitaltherapies.com
  • Transaction Type
    IPO
  • Transaction Amount
    $54,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy